JPMorgan Chase & Co’s Autolus Therapeutics AUTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.09M Sell
914,743
-495,361
-35% -$1.13M ﹤0.01% 3314
2025
Q1
$2.19M Buy
1,410,104
+338,571
+32% +$525K ﹤0.01% 3201
2024
Q4
$2.52M Sell
1,071,533
-213,175
-17% -$501K ﹤0.01% 3249
2024
Q3
$4.66M Buy
1,284,708
+761,008
+145% +$2.76M ﹤0.01% 2683
2024
Q2
$1.82M Buy
523,700
+394,791
+306% +$1.37M ﹤0.01% 3167
2024
Q1
$822K Buy
128,909
+101,476
+370% +$647K ﹤0.01% 3683
2023
Q4
$177K Buy
27,433
+27,327
+25,780% +$176K ﹤0.01% 4508
2023
Q3
$247 Sell
106
-1,693
-94% -$3.95K ﹤0.01% 5854
2023
Q2
$4.28K Sell
1,799
-439,226
-100% -$1.05M ﹤0.01% 5302
2023
Q1
$811K Sell
441,025
-52,484
-11% -$96.5K ﹤0.01% 3565
2022
Q4
$938K Buy
493,509
+50,959
+12% +$96.9K ﹤0.01% 3390
2022
Q3
$947K Sell
442,550
-183,969
-29% -$394K ﹤0.01% 3393
2022
Q2
$1.77M Sell
626,519
-173,039
-22% -$490K ﹤0.01% 3094
2022
Q1
$3.33M Sell
799,558
-51,986
-6% -$217K ﹤0.01% 2838
2021
Q4
$4.42M Sell
851,544
-499,811
-37% -$2.59M ﹤0.01% 2669
2021
Q3
$8.85M Buy
1,351,355
+600,391
+80% +$3.93M ﹤0.01% 2146
2021
Q2
$4.99M Buy
750,964
+196,595
+35% +$1.31M ﹤0.01% 2642
2021
Q1
$3.18M Buy
554,369
+300,109
+118% +$1.72M ﹤0.01% 2953
2020
Q4
$2.27M Buy
254,260
+75,626
+42% +$676K ﹤0.01% 2888
2020
Q3
$2.14M Buy
178,634
+37,879
+27% +$455K ﹤0.01% 2707
2020
Q2
$2.26M Buy
140,755
+39,308
+39% +$630K ﹤0.01% 2621
2020
Q1
$608K Buy
101,447
+63,234
+165% +$379K ﹤0.01% 3216
2019
Q4
$504K Buy
+38,213
New +$504K ﹤0.01% 3418